Gain Therapeutics Inc
GANX
$1.26-5.26%
End of day · as of Oct 17, 2026, 2:00 AM ET
Mkt cap
$53.00M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2023-09-30)
$55,180
EPS (H1 2026)
$-0.24
Gross Margin (qtr ended 2023-09-30)
N/A
Profit Margin (qtr ended 2023-09-30)
-8550.68%
Beta
0.11
Div yield
N/A
Sector
Healthcare
Gain Therapeutics Inc (GANX) is a biotechnology company listed on US.
Latest reported GANX revenue for 2023-09-30 was $55.2K. Net income was -$4.7M. Revenue was up 0.0% from 2023-06-30 to 2023-09-30. GANX currently screens at market cap $53.0M.
Use this GANX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full GANX income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Gain Therapeutics Inc (GANX) is a biotechnology company in the Healthcare sector.
Latest cached Gain Therapeutics Inc (GANX) revenue for Sep 30, 2023 was $55.2K. Net income was -$4.7M. Statements: https://lician.com/financials/ganx
Gain Therapeutics Inc (GANX) market capitalization is $53.0M on the latest cached snapshot.
Gain Therapeutics Inc (GANX) cached previous close $1.33; day range $1.26 – $1.32; volume 464,341. Session quote: https://lician.com/quote/ganx
Gain Therapeutics Inc (GANX) latest cached earnings event is "GANX earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached GANX filing is 8-K · Oct 1, 2026. Filings: https://lician.com/sec/ganx